Allarity Therapeutics Provides Third Quarter 2025 Financial Results and Provides Business Updates
Received FDA Fast Track designation for stenoparib in advanced ovarian cancer Reported landmark median overall survival now exceeding...
Cancer
Cantor Fitzgerald Reiterates Overweight Rating on Prenetics with Price Target of $31 Following Strong IM8 Growth
IM8’s Strong Unit Economics—60% Margins and 3.9-Month Payback—Central to Cantor’s Bullish Outlook Cantor Notes PRE’s ~$120M Liquidity and 387 BTC...
Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Total net revenue increased 20.5% to $17.6 million for third quarter of 2025 compared to the third quarter of 2024...
Advancing Rural Health: ECRI Collaborates with Massachusetts General Hospital on ARPA-H Initiative Developing Mobile Medical Units
WILLOW GROVE, Pa., Nov. 13, 2025 /PRNewswire/ -- What if we could deliver advanced hospital-level care to every rural county...
MiBA Expands Support for Value-Based Cancer Care Through Partnership with American Oncology Network
Strategic collaboration with AON strengthens MiBA's mission to enable data-driven, value-based oncology care through real-world evidence, and technology integration. TAMPA,...
Phio Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
Clinical Trial has Advanced to Fifth and Final Cohort at Maximum Dose of INSTASYL PH-762 in Skin Cancer Trial Positive...
Clairity Raises $43 Million in Series B to Launch First FDA-Authorized AI Platform for Breast Cancer Risk Prediction
With backing from leading healthcare investors, Clairity accelerates its mission to predict and prevent breast cancer and expand into cardiovascular...
Clairity Raises $43 Million in Series B to Launch First FDA-Authorized AI Platform for Breast Cancer Risk Prediction
With backing from leading healthcare investors, Clairity accelerates its mission to predict and prevent breast cancer and expand into cardiovascular...
Impiricus Launches Ascend, An AI Platform To Ethically Connect Physicians And Pharma
Ascend sets a new standard in physician support through precision-tailored new resources to give patients faster, more reliable access to...
Strava and GoFundMe Team Up to Empower Athletes to Move “For a Cause”
New feature makes it easy for Strava users to raise awareness and funds for meaningful causes through activity SAN FRANCISCO,...
Embr Wave “personal thermostat” wearable now delivers temperature automatically
BOSTON, Nov. 13, 2025 /PRNewswire/ -- Embr Labs, Inc, makers of the Embr Wave Smart Cooling & Warming Wristband, have...
Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
THE SKNJCT-003 CLINICAL STUDY EXPANSION INTO THE UNITED KINGDOM TO FURTHER ENABLE GLOBAL PATIENT RECRUITMENT AND CLINICAL DATASET TOWARD A...
Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger
Strategic transaction supports the advancement of Decoy’s rapid computational design and manufacturing of innovative peptide conjugate therapeutics through its IMP3ACT™...
Moleculin Reports 60% of First 45 Subjects in Pivotal “MIRACLE” Phase 3 AML Trial Consented
Completion of treatment for the first 45 patients on pace for Q1 2026 with initial unblinded data thereafter; blinded response...
Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates
Authorization Received from UK and EU Authorities to Activate ex-US Clinical Trial Sites Supporting the Ongoing Patient Enrollment of FT819,...
Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040
Once issued, this new U.S. patent covers the use of CardiolRx™ and CRD-38 for a broad range of cardiac disorders,...
Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040
Once issued, this new U.S. patent covers the use of CardiolRx™ and CRD-38 for a broad range of cardiac disorders,...
NanoViricides Announces Closing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close
SHELTON, CONNECTICUT / ACCESS Newswire / November 12, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), today announced the closing...
Advarra and IgniteData Announce Partnership to Simplify Clinical Trial Data Transfer for Research Sites
IgniteData's Archer platform will connect the site's EHR system, Advarra's eSource and EDC systems, and the sponsor's EDC system of...
Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s
Patent Extends Protection for Novel Vaccine Targeting a Cancer Projected to Strike Nearly 300,000 U.S. Women in 2026 SAN JOSE,...